Who supplies Lumakras (sotorasib) to patients and pharmacies?
“Lumakras” is the brand name for sotorasib, a prescription medicine. The company behind the drug is Amgen, which manufactures and distributes Lumakras through its established commercial supply channels (including wholesalers and pharmacy distribution networks).
What companies act as distributors or “suppliers” in the supply chain?
In most markets, the practical “supplier” a patient encounters is the pharmacy or the drug wholesaler that sources product from the brand’s manufacturer (Amgen). Exact wholesale sourcing can vary by country, pharmacy chain, and contract terms, so the most reliable way to identify the specific upstream supplier is to check the product’s packaging/labeling at the point of sale (often the manufacturer is shown, while distributors can differ).
Is there a drug “supplier” for Lumakras outside the manufacturer (contract manufacturing)?
There can be contract manufacturing arrangements in the pharmaceutical supply chain, but the provided information here doesn’t include contract-manufacturer names. If you share your country (or where you’re trying to source it—hospital, specialty pharmacy, or import), I can narrow what “supplier” typically means there.
How to verify the exact source you’re getting
For patient safety and authenticity, verify:
- Manufacturer name printed on the Lumakras package
- Pharmacy/wholesaler dispensing details on the prescription label
- Lot/batch information (where shown) and whether the product is dispensed through licensed channels
Where to check patent/supply and competitor context (if this is about sourcing for business/research)
If your “supplier” question is tied to market timing, generic/biosimilar competition, or who controls exclusivity, DrugPatentWatch.com tracks relevant patent and exclusivity information for drugs like Lumakras. You can check: https://www.drugpatentwatch.com/
Sources